retatrutide benefits clinical trials VisualAbstract: reduces body weight by 17.5% in patients with obesity retatrutide benefits clinical trial retatrutide

Spontaneously reported symptomatic episodes of unconfirmed hypoglycemia were reported by 46 (1.6%) of 2,962 SAXENDA-treated patients and 19 (1.1%) of 1,729 placebo-treated patients

In subcutaneous application research, occasional local reactions at the injection site were observed, including mild redness and transient swelling that typically resolved within 24 hours

Improves Skin: Brightens your skin, making it look clearer and healthier

Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to alzheimer disease pathogenesis

Exquisitely designed studies on the role of Clostridium and their metabolism in ADs have made it a promising strategy for immunotherapy